CT1194C
/ Institute of Hematology and Blood Diseases Hospital
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 17, 2025
A Clinical Study Exploring CT1194C in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
(clinicaltrials.gov)
- P1 | N=27 | Not yet recruiting | Sponsor: Institute of Hematology & Blood Diseases Hospital, China
New P1 trial • B Cell Non-Hodgkin Lymphoma • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology
1 to 1
Of
1
Go to page
1